A REVIEW OF THE ANTICANCER NATURAL PRODUCTS: ALKALOIDS, FLAVONOIDS
Open Access
- 26 August 2022
- journal article
- review article
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 18-19,p. 391-393
Abstract
According to the international agency for research on cancer 1 in 5 people develop cancer during their lifetime, suggesting that more than 50 million people are living within five years of a past cancer diagnosis (World Health Organization (WHO, 2020, para. 1). Despite novel approaches like nanomedicine, targeted therapy, and immunotherapy in cancer treatments during the last decades, chemoresistance has remained the chief hurdle in eliminating cancerous cells (Elgendy , Alyammahi & Alhamad, 2020, p. 103095). About 9 out of 10 cancer deaths are due to spreading of cancer cells from the primary tumor mass towards close and far tissues (a process called metastasis). Treatment failure followed by consequent recurrence of cancer cells and metastasis is the leading cause of death. Many survivors suffer from serious acute or chronic complications after cancer therapy (Qian, Mei, & Zhang, 2017, p.38). Furthermore, chemotherapy commonly induces a variety of side-effects in patients as a result of nonspecific action against both normal cells and cancerous cells. For instance, chemotherapeutic drugs result in alopecia by affecting not only fast dividing cancer cells, but hair follicles as well. Nausea and vomiting are the most common symptoms induced by chemotherapy, with gastrointestinal symptoms including diarrhea (and in some cases constipation) being another common side effect. Chemotherapy is also known to impair immune function and bone marrow activity (Li et al., 2020, p.599073). The identification of approved doses of anticancer drugs is another point to be given careful attention, especially those with higher cost and administered for a longer duration. Larger doses of chemotherapeutic drugs may increase the risk and severity of the aforementioned side effects, and are not cost-saving. Therefore, phytomedicines should be considered as an option not only for adjuvant therapy, but also in view of their comparatively low toxicity and ability to diminish adverse effects of chemotherapy in cancer patients. Natural products and their derivatives can be used as novel therapeutic interventions with improved pharmacological properties targeting tumor cells (Meriggi & Zaniboni, 2020, pp.1–11).Keywords
This publication has 8 references indexed in Scilit:
- Therapeutic role of flavonoids and flavones in cancer prevention: Current trends and future perspectivesEuropean Journal of Medicinal Chemistry Reports, 2021
- Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic ReviewBiomedicines, 2021
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-AnalysisFrontiers in Oncology, 2020
- Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistanceCritical Reviews in Oncology/Hematology, 2020
- An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapyBiomaterials, 2020
- ‘The same old story’: thoughts on authorized doses of anticancer drugsTherapeutic Advances in Medical Oncology, 2020
- Cancer metastasis: issues and challengesChinese Journal of Cancer, 2017
- Light-Induced Cytosolic Activation of Reduction-Sensitive Camptothecin-Loaded Polymeric Micelles for Spatiotemporally Controlled in Vivo ChemotherapyACS Nano, 2014